No registrations found.
ID
Source
Brief title
Health condition
Cardiovascular risk factors
insulin resistency
reumatoid arthritis
Sponsors and support
Intervention
Outcome measures
Primary outcome
Metabolic syndrome / insulin resistence
Disease (RA) activity
Background summary
- To systematically determine metabolic adverse affects of RA patients, who (chronically) use GCs in order to reduce disease activity, compared to RA patients who don’t use GCs.
- To study the relation between disease activity, treatment, and metabolic syndrome / insulin resistance.
Study objective
What is the relation between disease activity, treatment, and metabolic syndrome / insulin resistance.
Intervention
1. Oral Glucose Tolerance Test (OGTT).
2. X-rays of hand, feet, lungs and spinal cord.
3. Electrocardiogram (ECG).
Dept. rheumatology & clinical immunology (F02.127)
Jos N. Hoes
Heidelberglaan 100
Utrecht 3584 RD
The Netherlands
+31 30 250 5240
mail@hoesjn.org
Dept. rheumatology & clinical immunology (F02.127)
Jos N. Hoes
Heidelberglaan 100
Utrecht 3584 RD
The Netherlands
+31 30 250 5240
mail@hoesjn.org
Inclusion criteria
Diagnosis reumatoïd arthritis with disease duration > 2 years.
Exclusion criteria
none
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL999 |
| NTR-old | NTR1028 |
| Other | : |
| ISRCTN | ISRCTN53261020 |